Korean Circulation Journal

The Korean Society of Cardiology (대한심장학회)
권호 표지
DOI QR코드

DOI QR Code

Staged Complete Revascularization in ST-Segment Elevation Myocardial Infarction Should Be the Treatment of Choice Compared to Primary Complete Revascularization

  • Lim, Do-Sun (Department of Cardiology, Cardiovascular Center, Korea University College of Medicine, Anam Hospital)
  • Published : 2011.12.30
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Smith SC Jr, Feldman TE, Hirshfeld JW Jr, et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (ACC/AHA/SCAI Writing Committee to update the 2001 guidelines for percutaneous coronary intervention). Circulation 2006;113:156-75. https://doi.org/10.1161/CIRCULATIONAHA.105.557561
  2. Smith SC Jr, Feldman TE, Hirshfeld JW Jr, et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 guidelines for percutaneous coronary intervention). Circulation 2006;113:e166-286. https://doi.org/10.1161/CIRCULATIONAHA.106.173220
  3. Varani E, Balducelli M, Aquilina M, et al. Single or multivessel percutaneous coronary intervention in ST-elevation myocardial infarction patients. Catheter Cardiovasc Interv 2008;72:927-33. https://doi.org/10.1002/ccd.21722
  4. Jo HS, Park JS, Sohn JW, et al. Culprit-lesion-only versus multivessel revascularization using drug-Eluting stents in patients with STsegment elevation myocardial infarction: a Korean Acute Myocardial Infarction Registry-Based Analysis. Korean Circ J 2011;41:718-25. https://doi.org/10.4070/kcj.2011.41.12.718
  5. Kornowski R, Mehran R, Dangas G, et al. Prognostic impact of staged versus "one-time" multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial. J Am Coll Cardiol 2011;58:704-11. https://doi.org/10.1016/j.jacc.2011.02.071
  6. Hannan EL, Samadashvili Z, Walford G, et al. Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease. JACC Cardiovasc Interv 2010;3:22-31. https://doi.org/10.1016/j.jcin.2009.10.017
  7. Vlaar PJ, Mahmoud KD, Holmes DR Jr, et al. Culprit vessel only versus multivessel and staged percutaneous coronary intervention for multivessel disease in patients presenting with ST-segment elevation myocardial infarction: a pairwise and network meta-analysis. J Am Coll Cardiol 2011;58:692-703. https://doi.org/10.1016/j.jacc.2011.03.046
  8. Brener SJ, Murphy SA, Gibson CM, DiBattiste PM, Demopoulos LA, Cannon CP. Efficacy and safety of multivessel percutaneous revascularization and tirofiban therapy in patients with acute coronary syndromes. Am J Cardiol 2002;90:631-3. https://doi.org/10.1016/S0002-9149(02)02569-9
  9. Shishehbor MH, Lauer MS, Singh IM, et al. In unstable angina or non-ST-segment acute coronary syndrome, should patients with multivessel coronary artery disease undergo multivessel or culprit-only stenting? J Am Coll Cardiol 2007;49:849-54. https://doi.org/10.1016/j.jacc.2006.10.054